ICR video toggle

Published: 12 January 2021

  • Views:

    Views Icon 98

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The Advancements in Atrial Fibrillation Detection and Treatment symposium brings together leading experts in the field of cardiology and electrophysiology to discuss topics including:

  • Atrial fibrillation (AF) detection tools and associated evidence: selecting the right device for each patient
  • How the latest AF detection devices can impact clinical practice
  • AF detection and treatment guidelines
  • The risk-benefit threshold of AF ablation compared to antiarrhythmic drug therapy
  • Who should be referred for an AF ablation
  • AF progression and the associated clinical impact
  • The benefits associated with early AF treatment and first-line ablation

Faculty: Prof. Thorsten Lewalter, Prof. Helmut Pürerfellner, and Prof. Carina Blomström-Lundqvist

This educational content is supported by Medtronic.

Learning objectives

  • AF detection tools that are best suited for different patients and how they can impact clinical practice
  • AF detection and treatment guidelines
  • Who should be referred for an AF ablation and what outcomes they can expect?
  • AF progression and the benefits of early treatment

Target Audience

  • The presentation recordings primarily target cardiologists. General practitioners, allied health professionals, and electrophysiologists may also benefit from this content.

More from this programme

Part 1

El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento

2 sessions
El futuro del manejo de la hipertensión: la denervación renal brinda otra opción de tratamiento Watch now
Test video Watch now

Part 2

Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption

1 session
Die Zukunft des Hypertoniemanagements – Renale Denervierung bietet eine weitere Behandlungsoption Watch now

Part 3

The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option

1 session
The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option Watch now

Part 4

The Science of Renal Denervation

1 session
The Science of Renal Denervation Watch now

Part 5

The science of renal denervation - Part 1

1 session
The science of renal denervation - Part 1 Watch now

Part 6

Can Renal Denervation Benefit Patients with Hypertension?

1 session
Can Renal Denervation Benefit Patients with Hypertension? Watch now

Part 7

TCT 2019: RF renal denervation - Prof Andrew Sharp

1 session
TCT 2019: RF renal denervation - Prof Andrew Sharp Watch now

Faculty Biographies

Justin E Davies

Justin E Davies

Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship.

Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including coronary wave intensity and instantaneous wave-free ratio (iFR). He is also published extensively in the field of hypertension and coronary and large artery physiology.

View full profile
Faisal Sharif

Faisal Sharif

Faisal Sharif is the Professor of Translational Cardiovascular Medicine and Innovation at National University of Ireland Galway and an Interventional Cardiologist at the Saolta Group, Galway University Hospital. He is also an Executive Director of BioInnovate Ireland, a multi disciplinary programme for novel medical device innovation. His research predominantly focuses on medical device innovation and clinical translation of novel medical devices and concepts for cardiovascular diseases.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.